Summary: Lupus erythematosus (LE) is a chronic autoimmune disease characterized by periods of exacerbation and remission. Skin lesions are the second most common symptom of systemic lupus erythematosus (SLE) and were included in the 2019 EULAR/ ACR classification criteria as one of seven clinical domains. They include acute, subacute, and chronic cutaneous lupus erythematosus, which together account for 14 diagnostic points. Cutaneous lupus erythematosus (CLE) may precede the development of SLE. The risk of progression within 3–5 years is then 5–18%. CLE can also occur as a separate disease entity without internal organ involvement, which is observed 2–3 times more often than SLE. Genetic and environmental factors play an important role in the pathogenesis of CLE, as in SLE. Based on the clinical picture, CLE is divided into acute (acute cutaneous lupus erythematosus, ACLE), subacute (subacute cutaneous lupus erythematosus, SCLE), and chronic (chronic cutaneous lupus erythematosus, CCLE). In addition to specific lesions, non-specific lesions may also occur, such as Raynaud's phenomenon or vasculitis. The diagnosis of CLE is based on the correct clinical classification of skin lesions, histopathological examination (most often with a picture of hydrophilic inflammation of the skin-epidermis border) and clinical and serological data, with simultaneous assessment of possible organ involvement. The aim of this review is to discuss the wide spectrum of skin manifestations of LE, from mild to severe, with particular emphasis on rarer and less known forms that are relevant in the practice of physicians of various specialties.